Citta Capital Research
Investment Thesis
Citta Capital is a Palo Alto, California-based venture capital firm founded in 2020 by Jim Mao. The firm's public positioning is "empowering extraordinary founders to build world-changing companies," and it invests across a deliberately broad set of technical categories rather than one narrow vertical: AI/ML, big data, cloud, healthcare technology, IoT, marketplaces, SaaS and enterprise software, blockchain, and robotics. The firm's own site language emphasizes a team with "a good mix of extensive startup experiences as entrepreneur and strong operating background as senior executive of global companies," positioning itself as a long-term partner rather than a purely transactional check-writer.
A recurring thread in the firm's public content (published via its Substack, cittacapital.substack.com, and amplified on LinkedIn) is a thesis about agentic AI restructuring how software and services are priced. The firm's writing on "selling work, not software" argues AI agents are shifting value capture away from seat-based software licensing toward outcome-based pricing for completed work, and that the biggest winners will be companies that absorb expensive, repeatable services work rather than simply adding a copilot on top of existing headcount. This thesis visibly informs recent portfolio activity in vertical AI-agent businesses such as Avoca (AI voice agents for home-services businesses).
Stage Focus
Citta describes itself as an early-stage and early-growth-stage investor. Its portfolio spans pre-seed (e.g., Kamiwaza) through growth-stage follow-ons in later rounds of existing portfolio companies (e.g., continued participation in Avoca's Series B).
Check Size
Third-party investor databases (NFX) place check sizes for the firm's investment team in the $100K-$5M range, with roughly $1.5M cited as a typical "sweet spot" check. This is consistent with a fund that participates alongside larger co-investors rather than always anchoring the largest check in a round.
Lead Tendency
Evidence points to a "follows/participates" pattern more often than "leads" at growth stage, though the firm appears to write first checks at the earliest stages. In Avoca's $125M cumulative raise to a $1B valuation (announced April 27, 2026), the round was anchored by Kleiner Perkins (Series A) and Meritech plus General Catalyst (Series B), with Citta among the broader group of backers rather than the lead. Earlier-stage checks, such as Kamiwaza's $2.5M pre-seed (announced January 2025), name Citta and founder Jim Mao specifically alongside other Seattle-area investors, suggesting more direct influence at the earliest stages.
Recent Activity
Citta has been active through 2025 and into 2026:
- January 2025: Pre-seed investment in enterprise AI platform Kamiwaza ($2.5M round).
- March 2025: Participated in Galatea Bio's $25M round to build a global genomic biobank for precision medicine.
- April 2026: Continued backing of Avoca, which announced more than $125M raised cumulatively across Seed through Series B at a $1B valuation, reaching unicorn status.
The firm also published its most visible piece of public thesis content, on selling completed AI-driven work rather than software licenses, amplified through its Substack and LinkedIn channels in 2026.
Portfolio Highlights
Confirmed current portfolio companies (from the firm's own portfolio page) include: Kamiwaza (enterprise AI deployment across cloud, core, and edge), Otis, Openprise (enterprise data/marketing operations), Avoca (AI voice agents for home-services businesses; reached unicorn status in April 2026), Honeycomb Credit (community small-business financing), OptimHire (AI-native hiring/HR SaaS), Visto (AI-driven GEO/marketing agent platform), Ex-Human (AI companion/character platform), Evil Genius Games (tabletop gaming studio), OrdaosBio (biotech therapeutics), Synaptec Health (digital/neuromodulation health), Setpoint Medical (bioelectronic medicine for autoimmune disease), Botrista (beverage-automation hardware for foodservice), Cambrian Robotics (industrial vision/robotics for manufacturing), and Finwave (fintech/finance infrastructure). Third-party aggregators (Tracxn, PitchBook, Crunchbase) additionally list Galatea Bio (genomic diversity biobank) and earlier positions such as Ryu Games (mobile cash-tournament gaming, acquired by Treasure in 2024).
Team
- Jim Mao, Founder & General Partner — the firm's founder and primary decision-maker since February 2020; prior experience as Partner at WestSummit Capital and Managing Director at Cagan McAfee Capital Partners.
- Fred Sun, Principal — Citta Capital investing principal with an individual check range of roughly $100K-$5M per third-party investor databases (NFX, Unicorn Nest).
- Shane Wilson, Venture Partner — splits time between sourcing/investing in early-stage B2B AI, deep tech, and robotics companies and working directly with founders; active on the firm's public content and at founder-investor events.
Decision Process
The firm reads as a small, founder-led shop. Third-party investor databases describe Jim Mao as the firm's sole General Partner, with Fred Sun and Shane Wilson in supporting principal/venture-partner roles rather than co-equal decision-making partners — consistent with a solo-GP decision process.
Founder Preferences
Citta's own language ("extraordinary founders," "game-changing ideas") and its portfolio composition suggest a preference for technical, category-defining founders in AI-native and deep-tech categories, alongside a willingness to back founders in less fashionable verticals (gaming, robotics, fintech infrastructure, food-service hardware) where a strong technical wedge exists.
Geographic Focus
Headquartered in Palo Alto, California; the confirmed and third-party-listed portfolio is predominantly US-based (California, New York, Miami, Seattle), with no strong evidence of an international investing focus.